Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number.
Szutowicz-Zielińska E, Konopa K, Kowalczyk A, Suszko-Każarnowicz M, Duchnowska R, Szczęsna A, Ratajska M, Sowa A, Limon J, Biernat W, Burzykowski T, Jassem J, Dziadziuszko R. Szutowicz-Zielińska E, et al. Among authors: konopa k. Oncotarget. 2017 Mar 7;8(10):17270-17278. doi: 10.18632/oncotarget.13793. Oncotarget. 2017. PMID: 27924059 Free PMC article. Clinical Trial.
Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance.
Jassem E, Bigda J, Dziadziuszko R, Schlichtholz B, Le Roux D, Grodzki T, Rzyman W, Konopa K, Poberezna M, Dobrzańska Z, Skokowski J, Soussi T, Jassem J. Jassem E, et al. Among authors: konopa k. Lung Cancer. 2001 Jan;31(1):17-23. doi: 10.1016/s0169-5002(00)00150-1. Lung Cancer. 2001. PMID: 11162862
(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.
Wełnicka-Jaśkiewicz M, Zaczek A, Brandt B, Bielawski KP, Jaśkiewicz J, Konopa K, Jassem J. Wełnicka-Jaśkiewicz M, et al. Among authors: konopa k. Eur J Cancer. 2006 Aug;42(12):1698-701. doi: 10.1016/j.ejca.2006.03.012. Epub 2006 Jun 12. Eur J Cancer. 2006. PMID: 16765588
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial.
Dziadziuszko R, Peters S, Mok T, Camidge DR, Gadgeel SM, Ou SI, Konopa K, Noé J, Nowicka M, Bordogna W, Morcos PN, Smoljanovic V, Shaw AT. Dziadziuszko R, et al. Among authors: konopa k. Clin Cancer Res. 2022 May 2;28(9):1800-1808. doi: 10.1158/1078-0432.CCR-21-2840. Clin Cancer Res. 2022. PMID: 35275991 Free PMC article. Clinical Trial.
Contralateral esophageal sparing technique in definitive radiotherapy for non-small cell lung cancer: dosimetric parameters and normal tissue complication probability modeling.
Łazar-Poniatowska M, Kamińska J, Konopa K, Dziadziuszko R, Jassem J. Łazar-Poniatowska M, et al. Among authors: konopa k. Rep Pract Oncol Radiother. 2022 Dec 29;27(6):933-942. doi: 10.5603/RPOR.a2022.0110. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36632308 Free PMC article.
26 results